FDA's Drug Safety Oversight Board Looks To Promote Its Value
Executive Summary
FDA's Drug Safety Oversight Board is trying to promote its value to the medical and regulatory communities by highlighting its role in addressing postmarketing safety issues
You may also be interested in...
New Nimodipine Formulation Aimed At Reducing Fatal Medication Errors
Nymalize, an oral formulation of brain hemorrhage treatment nimodipine, aims to minimize serious risks associated with incorrect administration of older forms of the drug.
Behind Closed Doors: FDA Drug Safety Board Will Keep Its Decisions Private
The pharmaceutical industry and other FDA stakeholders should not hold their breath waiting for more details about the agency's Drug Safety Oversight Board recommendations or the extent of internal debate and disagreement at its monthly non-public meetings
Behind Closed Doors: FDA Drug Safety Board Will Keep Its Decisions Private
The pharmaceutical industry and other FDA stakeholders should not hold their breath waiting for more details about the agency's Drug Safety Oversight Board recommendations or the extent of internal debate and disagreement at its monthly non-public meetings